نتایج جستجو برای: prednisone

تعداد نتایج: 9193  

Journal: :European urology 2014
Dana E Rathkopf Matthew R Smith Johann S de Bono Christopher J Logothetis Neal D Shore Paul de Souza Karim Fizazi Peter F A Mulders Paul Mainwaring John D Hainsworth Tomasz M Beer Scott North Yves Fradet Hendrik Van Poppel Joan Carles Thomas W Flaig Eleni Efstathiou Evan Y Yu Celestia S Higano Mary-Ellen Taplin Thomas W Griffin Mary B Todd Margaret K Yu Youn C Park Thian Kheoh Eric J Small Howard I Scher Arturo Molina Charles J Ryan Fred Saad

BACKGROUND Abiraterone acetate (an androgen biosynthesis inhibitor) plus prednisone is approved for treating patients with metastatic castration-resistant prostate cancer (mCRPC). Study COU-AA-302 evaluated abiraterone acetate plus prednisone versus prednisone alone in mildly symptomatic or asymptomatic patients with progressive mCRPC without prior chemotherapy. OBJECTIVE Report the prespecif...

2017
Manru Zhou Jin Li Jingkai Wu Yajun Yang Xiaobing Zeng Xiaohua Lv Liao Cui Weimin Yao Yuyu Liu

In Traditional Chinese Medicine, Polygonum multiflorum (PM) is known for its anti-aging properties. A previous study by our group showed that extracts of PM were able to prevent and treat bone loss in vivo, and the active components emodin and 2,3,5,4,-tetrahydroxystilbene-2-O-β-glucoside (TSG) promoted the osteogenic differentiation of mesenchymal stem cells in vitro. The aim of the present st...

2017
Carlo Buonerba Guru Sonpavde Francesca Vitrone Davide Bosso Livio Puglia Michela Izzo Simona Iaccarino Luca Scafuri Margherita Muratore Francesca Foschini Brigitta Mucci Vincenzo Tortora Martina Pagliuca Dario Ribera Vittorio Riccio Rocco Morra Mirta Mosca Nicola Cesarano Ileana Di Costanzo Sabino De Placido Giuseppe Di Lorenzo

Background: Cabazitaxel is a second-generation taxane that is approved for use with concomitant low dose daily prednisone in metastatic castration resistant prostate cancer (mCRPC) after docetaxel failure. Since the role of daily corticosteroids in improving cabazitaxel efficacy or ameliorating its safety profile has not been adequately investigated so far, we compared outcomes of patients rece...

Journal: :The American journal of the medical sciences 2011
Gholam Reza Pishdad Parisa Pishdad Reza Pishdad

A 17-year-old boy sought endocrine advice for an unusual gynecomastia that inexplicably recurred whenever he was treated with prednisone. This began at the age of 14, when the patient was diagnosed as having Addison's disease and was first treated with prednisone. An ensuing breast enlargement caused him to stop the medication and a regression of the gynecomastia was observed. Breast enlargemen...

2012

3.1: Treatment of the initial episode of SSNS 3.1.1: We recommend that corticosteroid therapy (prednisone or prednisolone)* be given for at least 12 weeks. (1B) 3.1.1.1: We recommend that oral prednisone be administered as a single daily dose (1B) starting at 60 mg/m/d or 2 mg/kg/d to a maximum 60 mg/d. (1D) 3.1.1.2: We recommend that daily oral prednisone be given for 4–6 weeks (1C) followed b...

Journal: :Journal of Korean Society for Clinical Pharmacology and Therapeutics 1994

Journal: :Asian Journal of Chemistry 2014

Journal: :The Journal of Clinical Pharmacology 2018

Journal: :Journal of Pharmacokinetics and Biopharmaceutics 1976

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید